Abstract Submission

Please download the abstract submission form at the bottom of the screen and send the completed form to 112jsp[A]convention[D]co[D]jp( Please change [A] to @ and [D] to . ) by E-mail.

Information required for abstract submission

The first author from domestic institutions must be a member of the Japanese Society of Pathology. Authors who submit abstract from international institutions are not necessary to be a member of the society. * Except "Poster presentation - Undergraduate (Undergraduate students)" (Those who are applying for membership must enter "99" in the "Membership Number" box.)
Inquiries regarding membership can be obtained at the Secretariat Office of the Japanese Society of Pathology. The details of the contact can be found at the bottom of this page.

Monday, September 5, 2022 -	Monday, October 24, 2022 Monday, October 31 2022 Monday, November 14 2022

Presentation style

• Oral presentation

• Poster presentation

• Poster presentation（Undergraduate students）

• Poster presentation（Trainees）

• Poster presentation (Postgraduate students ⋅ Residents)

Please note that we may ask you to present in a different presentation style from your preferred at the time of abstract acceptance.

Keywords *required

Keywords 1 *
01	Diagnostic pathology ⋅ Human pathology
02	Experimental pathology
03	Others

Keywords 2 *
01	Interdisciplinary pathology
02	Systemic diseases
03	Oral cavity ⋅ Head and neck ⋅ Salivary glands
04	Heart
05	Vessels
06	Respiratory tract
07	Mediastinum ⋅ Thymus
08	Serosal membranes ⋅ Mesothelium ⋅ Somatic cavity
09	Upper gastrointestinal tract
10	Lower gastrointestinal tract
11	Liver
12	Biliary system
13	Pancreas
14	Breast
15	Endocrine organs
16	Urinary system
17	Male reproductive organs
18	Female reproductive organs
19	Placenta and perinatal pathology
20	Pediatric pathology
21	Central nervous system
22	Peripheral nervous system
23	Bone and soft tissue ⋅ Locomotor organs
24	Blood ⋅ Bone marrow
25	Lymph nodes
26	Spleen
27	Skin
28	Sensory organs
29	Others

Keywords 3-1 *
01	Neoplastic diseases
02	Inflammatory diseases
03	Infectious diseases
04	Chronic progressive diseases
05	Circulatory failure ⋅ Circulatory disturbance
06	Metabolic disorder ⋅ Degenerative disorder
07	Transplantation pathology
08	Intractable and rare diseases
09	Congenital disorder ⋅ Developmental anomaly
10	Radiation injury
11	Autopsy
12	Cytodiagnosis
13	Intraoperative consultation
14	Differential diagnosis
15	Immunohistochemistry ⋅ Diagnostic molecular pathology
16	Classification of Diseases
17	Evaluation of treatment effects ⋅ Therapeutic strategies
18	Epidemiology ⋅ Statistics
19	Image analysis ⋅ AI ⋅ Digital pathology
20	Information technology ⋅ Bioinformatics
21	Education ⋅ Medical staff
22	Quality control
23	Work-life balance
24	Chromosomal abnormality ⋅ Hereditary diseases
25	Animal disease models
26	Genetic risks ⋅ Environmental factors
27	Genetic mutation ⋅ Carcinogenesis
28	Gene expression ⋅ Epigenetics
29	Signal transduction ⋅ Cell proliferation ⋅ Cell cycle
30	Cell death ⋅ Cell damage ⋅ Senescence
31	Invasion and metastasis
32	Cancer microenvironment ⋅ Cancer stem cells
33	Cancer cellular characteristics
34	Cancer immunology
35	Diagnostic markers ⋅ Tumor markers ⋅ New therapies
36	Cell biology ⋅ Molecular imaging
37	Cell differentiation ⋅ Regenerative medicine
38	Development and developmental abnormalities
39	Immunity ⋅ Inflammation
40	Autoimmunity ⋅ Autoinflammation
41	Novel technology ⋅ Experimental technique
42	Others

Keywords 3-2 for Second Choice (The same keywords as Keywords 3-1)

Title

The title must be written in English.
Maximum number of letters: 100
*Titles with more than 100 letters cannot be registered.

Abstract (main text)

Abstract will be accepted in English only.
Maximum number of letters: 1040

Co-author(s) / affiliation(s)

Co-author(s): up to 10 persons including the first author Affiliation(s): up to 10 institutions List of abbreviations used for affiliations: here

Selection of abstracts

Submitted abstracts will be peer-reviewed, and acceptance and presentation style will be decided by the program committee. Notifications of accepted abstract will be sent by e-mail to the authors.